» Articles » PMID: 9009222

Lymph Node Localisation of Biodegradable Nanospheres Surface Modified with Poloxamer and Poloxamine Block Co-polymers

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 1997 Jan 6
PMID 9009222
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Studies were performed to develop a sub-100 nm biodegradable colloidal system for the efficient delivery of drugs and diagnostic agents to the lymphatic system. Nanospheres of poly(lactide-co-glycolide) were prepared by interfacial polymer deposition. The nanospheres were coated with block co-polymers in order to modify their surface characteristics. Radiolabelling of the nanospheres for in vivo tracing was achieved by the incorporation of the lipophilic complex 111In-oxine during nanosphere preparation. In vitro stability of the radiolabelled nanospheres was determined in rat serum at 37 degrees C. The lymphatic distribution of the nanospheres was determined after subcutaneous administration to the rat. Lymphatic uptake of all coated systems was enhanced compared to the uncoated nanospheres, and a maximal uptake of 17% of the administered dose in the regional lymph nodes was achieved. These observations suggest that the nanospheres are suitable for diagnostic and therapeutic applications in clinical and experimental medicine.

Citing Articles

Poloxamers Have Vaccine-Adjuvant Properties by Increasing Dissemination of Particulate Antigen at Distant Lymph Nodes.

Lamrayah M, Phelip C, Rovera R, Coiffier C, Lazhar N, Bartolomei F Molecules. 2023; 28(12).

PMID: 37375333 PMC: 10304813. DOI: 10.3390/molecules28124778.


Lymphatic Transport and Lymph Node Location of Microspheres Subcutaneously Injected in the Vicinity of Tumors in a Rabbit Model of Breast Cancer.

Pascale F, Bedouet L, Fazel A, Namur J, Ghegediban S, Cornil I Pharm Res. 2018; 35(10):191.

PMID: 30112583 DOI: 10.1007/s11095-018-2474-6.


In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles.

Kennedy J, Larraneta E, McCrudden M, McCrudden C, Brady A, Fallows S J Control Release. 2017; 265:57-65.

PMID: 28428065 PMC: 5736098. DOI: 10.1016/j.jconrel.2017.04.022.


Development of individualized anti-metastasis strategies by engineering nanomedicines.

He Q, Guo S, Qian Z, Chen X Chem Soc Rev. 2015; 44(17):6258-6286.

PMID: 26056688 PMC: 4540626. DOI: 10.1039/c4cs00511b.


A holistic approach to targeting disease with polymeric nanoparticles.

Cheng C, Tietjen G, Saucier-Sawyer J, Saltzman W Nat Rev Drug Discov. 2015; 14(4):239-47.

PMID: 25598505 PMC: 4451203. DOI: 10.1038/nrd4503.